nodes	percent_of_prediction	percent_of_DWPC	metapath
Atomoxetine—CYP3A4—Budesonide—ulcerative colitis	0.0636	0.124	CbGbCtD
Atomoxetine—CYP2C19—Nicotine—ulcerative colitis	0.0573	0.111	CbGbCtD
Atomoxetine—CYP2C19—Cholecalciferol—ulcerative colitis	0.0514	0.0999	CbGbCtD
Atomoxetine—CYP2D6—Nicotine—ulcerative colitis	0.0435	0.0847	CbGbCtD
Atomoxetine—CYP2D6—Cholecalciferol—ulcerative colitis	0.0391	0.076	CbGbCtD
Atomoxetine—CYP2C19—Prednisone—ulcerative colitis	0.0356	0.0693	CbGbCtD
Atomoxetine—CYP3A4—Methylprednisolone—ulcerative colitis	0.0284	0.0553	CbGbCtD
Atomoxetine—CYP3A4—Nicotine—ulcerative colitis	0.0277	0.0539	CbGbCtD
Atomoxetine—CYP3A4—Cholecalciferol—ulcerative colitis	0.0248	0.0483	CbGbCtD
Atomoxetine—CYP2C19—Dexamethasone—ulcerative colitis	0.0222	0.0432	CbGbCtD
Atomoxetine—CYP3A4—Triamcinolone—ulcerative colitis	0.0215	0.0419	CbGbCtD
Atomoxetine—CYP3A4—Betamethasone—ulcerative colitis	0.0185	0.0359	CbGbCtD
Atomoxetine—CYP3A4—Prednisolone—ulcerative colitis	0.0182	0.0355	CbGbCtD
Atomoxetine—CYP3A4—Hydrocortisone—ulcerative colitis	0.0173	0.0336	CbGbCtD
Atomoxetine—CYP3A4—Prednisone—ulcerative colitis	0.0172	0.0335	CbGbCtD
Atomoxetine—CYP2D6—Dexamethasone—ulcerative colitis	0.0169	0.0329	CbGbCtD
Atomoxetine—CYP3A4—Dexamethasone—ulcerative colitis	0.0107	0.0209	CbGbCtD
Atomoxetine—HTR2A—enteric nervous system—ulcerative colitis	0.00265	0.375	CbGeAlD
Atomoxetine—Ketoprofen—CXCR1—ulcerative colitis	0.00233	0.176	CrCbGaD
Atomoxetine—HTR2A—myenteric nerve plexus—ulcerative colitis	0.00201	0.284	CbGeAlD
Atomoxetine—Pseudoephedrine—IL2—ulcerative colitis	0.00132	0.0999	CrCbGaD
Atomoxetine—Phenoxybenzamine—CALM3—ulcerative colitis	0.00115	0.0869	CrCbGaD
Atomoxetine—Ketoprofen—CXCL8—ulcerative colitis	0.000589	0.0445	CrCbGaD
Atomoxetine—NPY1R—liver—ulcerative colitis	0.000556	0.0786	CbGeAlD
Atomoxetine—Ephedrine—ADRB2—ulcerative colitis	0.000522	0.0394	CrCbGaD
Atomoxetine—Fenoprofen—PTGS1—ulcerative colitis	0.000509	0.0385	CrCbGaD
Atomoxetine—Desipramine—SLC22A4—ulcerative colitis	0.000482	0.0364	CrCbGaD
Atomoxetine—Pseudoephedrine—TNF—ulcerative colitis	0.000446	0.0337	CrCbGaD
Atomoxetine—Diphenhydramine—SLC22A5—ulcerative colitis	0.000407	0.0307	CrCbGaD
Atomoxetine—Pseudoephedrine—ADRB2—ulcerative colitis	0.000395	0.0299	CrCbGaD
Atomoxetine—Desipramine—SLC22A5—ulcerative colitis	0.000362	0.0274	CrCbGaD
Atomoxetine—Reboxetine—ABCB1—ulcerative colitis	0.000331	0.025	CrCbGaD
Atomoxetine—Protriptyline—ABCB1—ulcerative colitis	0.000304	0.023	CrCbGaD
Atomoxetine—Ketoprofen—PTGS1—ulcerative colitis	0.0003	0.0227	CrCbGaD
Atomoxetine—Fenoprofen—PTGS2—ulcerative colitis	0.000291	0.022	CrCbGaD
Atomoxetine—SLC6A4—digestive system—ulcerative colitis	0.000288	0.0407	CbGeAlD
Atomoxetine—Phenoxybenzamine—ADRB2—ulcerative colitis	0.000282	0.0213	CrCbGaD
Atomoxetine—Syncope—Prednisolone—ulcerative colitis	0.000281	0.000816	CcSEcCtD
Atomoxetine—Urticaria—Mesalazine—ulcerative colitis	0.000279	0.00081	CcSEcCtD
Atomoxetine—Back pain—Triamcinolone—ulcerative colitis	0.000279	0.00081	CcSEcCtD
Atomoxetine—Propranolol—ADRB2—ulcerative colitis	0.000278	0.021	CrCbGaD
Atomoxetine—Abdominal pain—Mesalazine—ulcerative colitis	0.000278	0.000806	CcSEcCtD
Atomoxetine—Body temperature increased—Mesalazine—ulcerative colitis	0.000278	0.000806	CcSEcCtD
Atomoxetine—Loss of consciousness—Prednisolone—ulcerative colitis	0.000275	0.0008	CcSEcCtD
Atomoxetine—Vertigo—Hydrocortisone—ulcerative colitis	0.000275	0.000799	CcSEcCtD
Atomoxetine—Vomiting—Budesonide—ulcerative colitis	0.000275	0.000798	CcSEcCtD
Atomoxetine—Syncope—Hydrocortisone—ulcerative colitis	0.000274	0.000797	CcSEcCtD
Atomoxetine—Angiopathy—Dexamethasone—ulcerative colitis	0.000272	0.000791	CcSEcCtD
Atomoxetine—Angiopathy—Betamethasone—ulcerative colitis	0.000272	0.000791	CcSEcCtD
Atomoxetine—Rash—Budesonide—ulcerative colitis	0.000272	0.000791	CcSEcCtD
Atomoxetine—Dermatitis—Budesonide—ulcerative colitis	0.000272	0.00079	CcSEcCtD
Atomoxetine—Convulsion—Prednisolone—ulcerative colitis	0.000271	0.000789	CcSEcCtD
Atomoxetine—Headache—Budesonide—ulcerative colitis	0.000271	0.000786	CcSEcCtD
Atomoxetine—Loss of consciousness—Hydrocortisone—ulcerative colitis	0.000269	0.000781	CcSEcCtD
Atomoxetine—Convulsion—Hydrocortisone—ulcerative colitis	0.000265	0.00077	CcSEcCtD
Atomoxetine—Diarrhoea—Azathioprine—ulcerative colitis	0.000264	0.000766	CcSEcCtD
Atomoxetine—Myalgia—Hydrocortisone—ulcerative colitis	0.00026	0.000757	CcSEcCtD
Atomoxetine—Hallucination—Prednisone—ulcerative colitis	0.00026	0.000756	CcSEcCtD
Atomoxetine—Anxiety—Hydrocortisone—ulcerative colitis	0.00026	0.000754	CcSEcCtD
Atomoxetine—Fenoprofen—ALB—ulcerative colitis	0.000259	0.0196	CrCbGaD
Atomoxetine—Vertigo—Triamcinolone—ulcerative colitis	0.000259	0.000752	CcSEcCtD
Atomoxetine—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—ulcerative colitis	0.000259	0.000752	CcSEcCtD
Atomoxetine—Syncope—Triamcinolone—ulcerative colitis	0.000258	0.000751	CcSEcCtD
Atomoxetine—Vertigo—Methylprednisolone—ulcerative colitis	0.000258	0.00075	CcSEcCtD
Atomoxetine—Syncope—Methylprednisolone—ulcerative colitis	0.000258	0.000749	CcSEcCtD
Atomoxetine—Nausea—Budesonide—ulcerative colitis	0.000256	0.000745	CcSEcCtD
Atomoxetine—Dizziness—Azathioprine—ulcerative colitis	0.000255	0.000741	CcSEcCtD
Atomoxetine—Loss of consciousness—Triamcinolone—ulcerative colitis	0.000253	0.000736	CcSEcCtD
Atomoxetine—Loss of consciousness—Methylprednisolone—ulcerative colitis	0.000253	0.000734	CcSEcCtD
Atomoxetine—Asthenia—Mesalazine—ulcerative colitis	0.000252	0.000732	CcSEcCtD
Atomoxetine—Shock—Prednisolone—ulcerative colitis	0.000252	0.000731	CcSEcCtD
Atomoxetine—Cough—Triamcinolone—ulcerative colitis	0.000251	0.00073	CcSEcCtD
Atomoxetine—Convulsion—Triamcinolone—ulcerative colitis	0.00025	0.000725	CcSEcCtD
Atomoxetine—Tachycardia—Prednisolone—ulcerative colitis	0.00025	0.000725	CcSEcCtD
Atomoxetine—Convulsion—Methylprednisolone—ulcerative colitis	0.000249	0.000724	CcSEcCtD
Atomoxetine—Pruritus—Mesalazine—ulcerative colitis	0.000248	0.000722	CcSEcCtD
Atomoxetine—Infection—Hydrocortisone—ulcerative colitis	0.000248	0.000721	CcSEcCtD
Atomoxetine—Hyperhidrosis—Prednisolone—ulcerative colitis	0.000247	0.000718	CcSEcCtD
Atomoxetine—Shock—Hydrocortisone—ulcerative colitis	0.000246	0.000714	CcSEcCtD
Atomoxetine—Myalgia—Triamcinolone—ulcerative colitis	0.000245	0.000713	CcSEcCtD
Atomoxetine—Vomiting—Azathioprine—ulcerative colitis	0.000245	0.000712	CcSEcCtD
Atomoxetine—Nervous system disorder—Hydrocortisone—ulcerative colitis	0.000245	0.000711	CcSEcCtD
Atomoxetine—Myalgia—Methylprednisolone—ulcerative colitis	0.000245	0.000711	CcSEcCtD
Atomoxetine—Arthralgia—Methylprednisolone—ulcerative colitis	0.000245	0.000711	CcSEcCtD
Atomoxetine—Anxiety—Methylprednisolone—ulcerative colitis	0.000244	0.000709	CcSEcCtD
Atomoxetine—Tachycardia—Hydrocortisone—ulcerative colitis	0.000244	0.000708	CcSEcCtD
Atomoxetine—Rash—Azathioprine—ulcerative colitis	0.000243	0.000706	CcSEcCtD
Atomoxetine—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ulcerative colitis	0.000243	0.000706	CcSEcCtD
Atomoxetine—Dermatitis—Azathioprine—ulcerative colitis	0.000243	0.000706	CcSEcCtD
Atomoxetine—Flushing—Prednisone—ulcerative colitis	0.000243	0.000705	CcSEcCtD
Atomoxetine—Skin disorder—Hydrocortisone—ulcerative colitis	0.000243	0.000705	CcSEcCtD
Atomoxetine—Headache—Azathioprine—ulcerative colitis	0.000242	0.000702	CcSEcCtD
Atomoxetine—Hyperhidrosis—Hydrocortisone—ulcerative colitis	0.000241	0.000701	CcSEcCtD
Atomoxetine—Diarrhoea—Mesalazine—ulcerative colitis	0.00024	0.000698	CcSEcCtD
Atomoxetine—Dry mouth—Triamcinolone—ulcerative colitis	0.00024	0.000697	CcSEcCtD
Atomoxetine—Nortriptyline—PTGS1—ulcerative colitis	0.00024	0.0181	CrCbGaD
Atomoxetine—CYP2C19—digestive system—ulcerative colitis	0.000238	0.0337	CbGeAlD
Atomoxetine—Anorexia—Hydrocortisone—ulcerative colitis	0.000238	0.000691	CcSEcCtD
Atomoxetine—Angiopathy—Prednisone—ulcerative colitis	0.000237	0.000689	CcSEcCtD
Atomoxetine—Vertigo—Dexamethasone—ulcerative colitis	0.000235	0.000682	CcSEcCtD
Atomoxetine—Vertigo—Betamethasone—ulcerative colitis	0.000235	0.000682	CcSEcCtD
Atomoxetine—Syncope—Betamethasone—ulcerative colitis	0.000234	0.000681	CcSEcCtD
Atomoxetine—Syncope—Dexamethasone—ulcerative colitis	0.000234	0.000681	CcSEcCtD
Atomoxetine—Infection—Triamcinolone—ulcerative colitis	0.000234	0.000679	CcSEcCtD
Atomoxetine—Infection—Methylprednisolone—ulcerative colitis	0.000233	0.000677	CcSEcCtD
Atomoxetine—Dizziness—Mesalazine—ulcerative colitis	0.000232	0.000675	CcSEcCtD
Atomoxetine—Shock—Triamcinolone—ulcerative colitis	0.000231	0.000672	CcSEcCtD
Atomoxetine—Insomnia—Prednisolone—ulcerative colitis	0.000231	0.000672	CcSEcCtD
Atomoxetine—Shock—Methylprednisolone—ulcerative colitis	0.000231	0.000671	CcSEcCtD
Atomoxetine—Nervous system disorder—Methylprednisolone—ulcerative colitis	0.00023	0.000668	CcSEcCtD
Atomoxetine—Loss of consciousness—Dexamethasone—ulcerative colitis	0.00023	0.000667	CcSEcCtD
Atomoxetine—Loss of consciousness—Betamethasone—ulcerative colitis	0.00023	0.000667	CcSEcCtD
Atomoxetine—Paraesthesia—Prednisolone—ulcerative colitis	0.00023	0.000667	CcSEcCtD
Atomoxetine—Tachycardia—Triamcinolone—ulcerative colitis	0.000229	0.000667	CcSEcCtD
Atomoxetine—Mental disorder—Prednisone—ulcerative colitis	0.000229	0.000666	CcSEcCtD
Atomoxetine—Nausea—Azathioprine—ulcerative colitis	0.000229	0.000665	CcSEcCtD
Atomoxetine—Tachycardia—Methylprednisolone—ulcerative colitis	0.000229	0.000665	CcSEcCtD
Atomoxetine—Skin disorder—Methylprednisolone—ulcerative colitis	0.000228	0.000662	CcSEcCtD
Atomoxetine—Malnutrition—Prednisone—ulcerative colitis	0.000228	0.000661	CcSEcCtD
Atomoxetine—Musculoskeletal discomfort—Hydrocortisone—ulcerative colitis	0.000228	0.000661	CcSEcCtD
Atomoxetine—Hyperhidrosis—Triamcinolone—ulcerative colitis	0.000227	0.00066	CcSEcCtD
Atomoxetine—Hyperhidrosis—Methylprednisolone—ulcerative colitis	0.000227	0.000659	CcSEcCtD
Atomoxetine—Convulsion—Dexamethasone—ulcerative colitis	0.000226	0.000658	CcSEcCtD
Atomoxetine—Convulsion—Betamethasone—ulcerative colitis	0.000226	0.000658	CcSEcCtD
Atomoxetine—Insomnia—Hydrocortisone—ulcerative colitis	0.000226	0.000656	CcSEcCtD
Atomoxetine—Paraesthesia—Hydrocortisone—ulcerative colitis	0.000224	0.000651	CcSEcCtD
Atomoxetine—Phenprocoumon—ALB—ulcerative colitis	0.000224	0.0169	CrCbGaD
Atomoxetine—Vomiting—Mesalazine—ulcerative colitis	0.000223	0.000649	CcSEcCtD
Atomoxetine—Myalgia—Betamethasone—ulcerative colitis	0.000223	0.000647	CcSEcCtD
Atomoxetine—Myalgia—Dexamethasone—ulcerative colitis	0.000223	0.000647	CcSEcCtD
Atomoxetine—Anxiety—Dexamethasone—ulcerative colitis	0.000222	0.000644	CcSEcCtD
Atomoxetine—Anxiety—Betamethasone—ulcerative colitis	0.000222	0.000644	CcSEcCtD
Atomoxetine—Diphenhydramine—PTGS1—ulcerative colitis	0.000222	0.0167	CrCbGaD
Atomoxetine—Rash—Mesalazine—ulcerative colitis	0.000221	0.000643	CcSEcCtD
Atomoxetine—Dermatitis—Mesalazine—ulcerative colitis	0.000221	0.000643	CcSEcCtD
Atomoxetine—Headache—Mesalazine—ulcerative colitis	0.00022	0.000639	CcSEcCtD
Atomoxetine—Dyspepsia—Hydrocortisone—ulcerative colitis	0.00022	0.000639	CcSEcCtD
Atomoxetine—Pain—Prednisolone—ulcerative colitis	0.000219	0.000635	CcSEcCtD
Atomoxetine—Fluoxetine—ALB—ulcerative colitis	0.000217	0.0164	CrCbGaD
Atomoxetine—Decreased appetite—Hydrocortisone—ulcerative colitis	0.000217	0.000631	CcSEcCtD
Atomoxetine—Gastrointestinal disorder—Hydrocortisone—ulcerative colitis	0.000216	0.000626	CcSEcCtD
Atomoxetine—Fatigue—Hydrocortisone—ulcerative colitis	0.000215	0.000625	CcSEcCtD
Atomoxetine—Vision blurred—Prednisone—ulcerative colitis	0.000215	0.000623	CcSEcCtD
Atomoxetine—Musculoskeletal discomfort—Triamcinolone—ulcerative colitis	0.000214	0.000622	CcSEcCtD
Atomoxetine—Musculoskeletal discomfort—Methylprednisolone—ulcerative colitis	0.000214	0.000621	CcSEcCtD
Atomoxetine—Pain—Hydrocortisone—ulcerative colitis	0.000214	0.00062	CcSEcCtD
Atomoxetine—Insomnia—Triamcinolone—ulcerative colitis	0.000213	0.000618	CcSEcCtD
Atomoxetine—Insomnia—Methylprednisolone—ulcerative colitis	0.000212	0.000616	CcSEcCtD
Atomoxetine—Infection—Dexamethasone—ulcerative colitis	0.000212	0.000616	CcSEcCtD
Atomoxetine—Infection—Betamethasone—ulcerative colitis	0.000212	0.000616	CcSEcCtD
Atomoxetine—Paraesthesia—Triamcinolone—ulcerative colitis	0.000211	0.000613	CcSEcCtD
Atomoxetine—Feeling abnormal—Prednisolone—ulcerative colitis	0.000211	0.000612	CcSEcCtD
Atomoxetine—Paraesthesia—Methylprednisolone—ulcerative colitis	0.000211	0.000612	CcSEcCtD
Atomoxetine—Desipramine—ADRB2—ulcerative colitis	0.00021	0.0159	CrCbGaD
Atomoxetine—Shock—Dexamethasone—ulcerative colitis	0.00021	0.00061	CcSEcCtD
Atomoxetine—Shock—Betamethasone—ulcerative colitis	0.00021	0.00061	CcSEcCtD
Atomoxetine—Nervous system disorder—Betamethasone—ulcerative colitis	0.000209	0.000608	CcSEcCtD
Atomoxetine—Nervous system disorder—Dexamethasone—ulcerative colitis	0.000209	0.000608	CcSEcCtD
Atomoxetine—Agitation—Prednisone—ulcerative colitis	0.000209	0.000608	CcSEcCtD
Atomoxetine—Nausea—Mesalazine—ulcerative colitis	0.000209	0.000606	CcSEcCtD
Atomoxetine—Tachycardia—Betamethasone—ulcerative colitis	0.000208	0.000605	CcSEcCtD
Atomoxetine—Tachycardia—Dexamethasone—ulcerative colitis	0.000208	0.000605	CcSEcCtD
Atomoxetine—Fluoxetine—ABCB1—ulcerative colitis	0.000207	0.0157	CrCbGaD
Atomoxetine—Dyspepsia—Triamcinolone—ulcerative colitis	0.000207	0.000601	CcSEcCtD
Atomoxetine—Dyspepsia—Methylprednisolone—ulcerative colitis	0.000207	0.0006	CcSEcCtD
Atomoxetine—Hyperhidrosis—Betamethasone—ulcerative colitis	0.000206	0.000599	CcSEcCtD
Atomoxetine—Hyperhidrosis—Dexamethasone—ulcerative colitis	0.000206	0.000599	CcSEcCtD
Atomoxetine—Feeling abnormal—Hydrocortisone—ulcerative colitis	0.000206	0.000598	CcSEcCtD
Atomoxetine—Vertigo—Prednisone—ulcerative colitis	0.000205	0.000594	CcSEcCtD
Atomoxetine—Gastrointestinal pain—Hydrocortisone—ulcerative colitis	0.000204	0.000593	CcSEcCtD
Atomoxetine—Syncope—Prednisone—ulcerative colitis	0.000204	0.000593	CcSEcCtD
Atomoxetine—Anorexia—Dexamethasone—ulcerative colitis	0.000203	0.000591	CcSEcCtD
Atomoxetine—Anorexia—Betamethasone—ulcerative colitis	0.000203	0.000591	CcSEcCtD
Atomoxetine—Urticaria—Prednisolone—ulcerative colitis	0.000203	0.00059	CcSEcCtD
Atomoxetine—Fatigue—Triamcinolone—ulcerative colitis	0.000203	0.000589	CcSEcCtD
Atomoxetine—Fatigue—Methylprednisolone—ulcerative colitis	0.000202	0.000588	CcSEcCtD
Atomoxetine—Pain—Triamcinolone—ulcerative colitis	0.000201	0.000584	CcSEcCtD
Atomoxetine—Loss of consciousness—Prednisone—ulcerative colitis	0.0002	0.000581	CcSEcCtD
Atomoxetine—HTR2A—epithelium—ulcerative colitis	0.0002	0.0283	CbGeAlD
Atomoxetine—Urticaria—Hydrocortisone—ulcerative colitis	0.000198	0.000576	CcSEcCtD
Atomoxetine—Warfarin—ALB—ulcerative colitis	0.000198	0.015	CrCbGaD
Atomoxetine—Abdominal pain—Hydrocortisone—ulcerative colitis	0.000197	0.000573	CcSEcCtD
Atomoxetine—Body temperature increased—Hydrocortisone—ulcerative colitis	0.000197	0.000573	CcSEcCtD
Atomoxetine—Convulsion—Prednisone—ulcerative colitis	0.000197	0.000573	CcSEcCtD
Atomoxetine—Musculoskeletal discomfort—Betamethasone—ulcerative colitis	0.000194	0.000565	CcSEcCtD
Atomoxetine—Musculoskeletal discomfort—Dexamethasone—ulcerative colitis	0.000194	0.000565	CcSEcCtD
Atomoxetine—Maprotiline—ABCB1—ulcerative colitis	0.000194	0.0146	CrCbGaD
Atomoxetine—Myalgia—Prednisone—ulcerative colitis	0.000194	0.000563	CcSEcCtD
Atomoxetine—Arthralgia—Prednisone—ulcerative colitis	0.000194	0.000563	CcSEcCtD
Atomoxetine—Feeling abnormal—Triamcinolone—ulcerative colitis	0.000194	0.000563	CcSEcCtD
Atomoxetine—Feeling abnormal—Methylprednisolone—ulcerative colitis	0.000193	0.000562	CcSEcCtD
Atomoxetine—Anxiety—Prednisone—ulcerative colitis	0.000193	0.000561	CcSEcCtD
Atomoxetine—Insomnia—Betamethasone—ulcerative colitis	0.000193	0.000561	CcSEcCtD
Atomoxetine—Insomnia—Dexamethasone—ulcerative colitis	0.000193	0.000561	CcSEcCtD
Atomoxetine—HTR2A—smooth muscle tissue—ulcerative colitis	0.000193	0.0273	CbGeAlD
Atomoxetine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ulcerative colitis	0.000192	0.000559	CcSEcCtD
Atomoxetine—Gastrointestinal pain—Methylprednisolone—ulcerative colitis	0.000192	0.000557	CcSEcCtD
Atomoxetine—Paraesthesia—Dexamethasone—ulcerative colitis	0.000192	0.000557	CcSEcCtD
Atomoxetine—Paraesthesia—Betamethasone—ulcerative colitis	0.000192	0.000557	CcSEcCtD
Atomoxetine—Dyspepsia—Betamethasone—ulcerative colitis	0.000188	0.000546	CcSEcCtD
Atomoxetine—Dyspepsia—Dexamethasone—ulcerative colitis	0.000188	0.000546	CcSEcCtD
Atomoxetine—Urticaria—Triamcinolone—ulcerative colitis	0.000187	0.000543	CcSEcCtD
Atomoxetine—Urticaria—Methylprednisolone—ulcerative colitis	0.000186	0.000541	CcSEcCtD
Atomoxetine—Body temperature increased—Triamcinolone—ulcerative colitis	0.000186	0.00054	CcSEcCtD
Atomoxetine—Abdominal pain—Methylprednisolone—ulcerative colitis	0.000185	0.000539	CcSEcCtD
Atomoxetine—Decreased appetite—Betamethasone—ulcerative colitis	0.000185	0.000539	CcSEcCtD
Atomoxetine—Decreased appetite—Dexamethasone—ulcerative colitis	0.000185	0.000539	CcSEcCtD
Atomoxetine—Propafenone—ABCB1—ulcerative colitis	0.000185	0.014	CrCbGaD
Atomoxetine—Infection—Prednisone—ulcerative colitis	0.000185	0.000536	CcSEcCtD
Atomoxetine—Gastrointestinal disorder—Dexamethasone—ulcerative colitis	0.000184	0.000535	CcSEcCtD
Atomoxetine—Gastrointestinal disorder—Betamethasone—ulcerative colitis	0.000184	0.000535	CcSEcCtD
Atomoxetine—Fatigue—Dexamethasone—ulcerative colitis	0.000184	0.000534	CcSEcCtD
Atomoxetine—Fatigue—Betamethasone—ulcerative colitis	0.000184	0.000534	CcSEcCtD
Atomoxetine—Shock—Prednisone—ulcerative colitis	0.000183	0.000531	CcSEcCtD
Atomoxetine—Pain—Betamethasone—ulcerative colitis	0.000182	0.00053	CcSEcCtD
Atomoxetine—Pain—Dexamethasone—ulcerative colitis	0.000182	0.00053	CcSEcCtD
Atomoxetine—Nervous system disorder—Prednisone—ulcerative colitis	0.000182	0.000529	CcSEcCtD
Atomoxetine—Tachycardia—Prednisone—ulcerative colitis	0.000181	0.000527	CcSEcCtD
Atomoxetine—Skin disorder—Prednisone—ulcerative colitis	0.00018	0.000524	CcSEcCtD
Atomoxetine—Hyperhidrosis—Prednisone—ulcerative colitis	0.00018	0.000522	CcSEcCtD
Atomoxetine—Asthenia—Hydrocortisone—ulcerative colitis	0.000179	0.00052	CcSEcCtD
Atomoxetine—CYP2C19—liver—ulcerative colitis	0.000178	0.0251	CbGeAlD
Atomoxetine—Anorexia—Prednisone—ulcerative colitis	0.000177	0.000514	CcSEcCtD
Atomoxetine—Pruritus—Hydrocortisone—ulcerative colitis	0.000177	0.000513	CcSEcCtD
Atomoxetine—Feeling abnormal—Dexamethasone—ulcerative colitis	0.000176	0.000511	CcSEcCtD
Atomoxetine—Feeling abnormal—Betamethasone—ulcerative colitis	0.000176	0.000511	CcSEcCtD
Atomoxetine—Gastrointestinal pain—Betamethasone—ulcerative colitis	0.000174	0.000507	CcSEcCtD
Atomoxetine—Gastrointestinal pain—Dexamethasone—ulcerative colitis	0.000174	0.000507	CcSEcCtD
Atomoxetine—Ketoprofen—PTGS2—ulcerative colitis	0.000172	0.013	CrCbGaD
Atomoxetine—Diarrhoea—Hydrocortisone—ulcerative colitis	0.000171	0.000496	CcSEcCtD
Atomoxetine—Urticaria—Betamethasone—ulcerative colitis	0.000169	0.000492	CcSEcCtD
Atomoxetine—Urticaria—Dexamethasone—ulcerative colitis	0.000169	0.000492	CcSEcCtD
Atomoxetine—Musculoskeletal discomfort—Prednisone—ulcerative colitis	0.000169	0.000492	CcSEcCtD
Atomoxetine—Dizziness—Prednisolone—ulcerative colitis	0.000169	0.000491	CcSEcCtD
Atomoxetine—Asthenia—Triamcinolone—ulcerative colitis	0.000169	0.00049	CcSEcCtD
Atomoxetine—Abdominal pain—Betamethasone—ulcerative colitis	0.000169	0.00049	CcSEcCtD
Atomoxetine—Body temperature increased—Dexamethasone—ulcerative colitis	0.000169	0.00049	CcSEcCtD
Atomoxetine—Abdominal pain—Dexamethasone—ulcerative colitis	0.000169	0.00049	CcSEcCtD
Atomoxetine—Body temperature increased—Betamethasone—ulcerative colitis	0.000169	0.00049	CcSEcCtD
Atomoxetine—Asthenia—Methylprednisolone—ulcerative colitis	0.000168	0.000489	CcSEcCtD
Atomoxetine—Insomnia—Prednisone—ulcerative colitis	0.000168	0.000488	CcSEcCtD
Atomoxetine—Paraesthesia—Prednisone—ulcerative colitis	0.000167	0.000485	CcSEcCtD
Atomoxetine—Pruritus—Triamcinolone—ulcerative colitis	0.000166	0.000483	CcSEcCtD
Atomoxetine—Pruritus—Methylprednisolone—ulcerative colitis	0.000166	0.000482	CcSEcCtD
Atomoxetine—Dizziness—Hydrocortisone—ulcerative colitis	0.000165	0.00048	CcSEcCtD
Atomoxetine—Dyspepsia—Prednisone—ulcerative colitis	0.000164	0.000475	CcSEcCtD
Atomoxetine—Decreased appetite—Prednisone—ulcerative colitis	0.000162	0.000469	CcSEcCtD
Atomoxetine—Rash—Prednisolone—ulcerative colitis	0.000161	0.000468	CcSEcCtD
Atomoxetine—Dermatitis—Prednisolone—ulcerative colitis	0.000161	0.000468	CcSEcCtD
Atomoxetine—Diarrhoea—Methylprednisolone—ulcerative colitis	0.000161	0.000466	CcSEcCtD
Atomoxetine—Fatigue—Prednisone—ulcerative colitis	0.00016	0.000465	CcSEcCtD
Atomoxetine—Headache—Prednisolone—ulcerative colitis	0.00016	0.000465	CcSEcCtD
Atomoxetine—Constipation—Prednisone—ulcerative colitis	0.000159	0.000462	CcSEcCtD
Atomoxetine—Vomiting—Hydrocortisone—ulcerative colitis	0.000159	0.000461	CcSEcCtD
Atomoxetine—Rash—Hydrocortisone—ulcerative colitis	0.000157	0.000457	CcSEcCtD
Atomoxetine—Dermatitis—Hydrocortisone—ulcerative colitis	0.000157	0.000457	CcSEcCtD
Atomoxetine—Headache—Hydrocortisone—ulcerative colitis	0.000156	0.000454	CcSEcCtD
Atomoxetine—Dizziness—Triamcinolone—ulcerative colitis	0.000155	0.000452	CcSEcCtD
Atomoxetine—Dizziness—Methylprednisolone—ulcerative colitis	0.000155	0.000451	CcSEcCtD
Atomoxetine—Feeling abnormal—Prednisone—ulcerative colitis	0.000153	0.000445	CcSEcCtD
Atomoxetine—Asthenia—Dexamethasone—ulcerative colitis	0.000153	0.000445	CcSEcCtD
Atomoxetine—Asthenia—Betamethasone—ulcerative colitis	0.000153	0.000445	CcSEcCtD
Atomoxetine—Ketoprofen—ALB—ulcerative colitis	0.000153	0.0116	CrCbGaD
Atomoxetine—HTR2A—digestive system—ulcerative colitis	0.000152	0.0215	CbGeAlD
Atomoxetine—Gastrointestinal pain—Prednisone—ulcerative colitis	0.000152	0.000441	CcSEcCtD
Atomoxetine—Nausea—Prednisolone—ulcerative colitis	0.000152	0.000441	CcSEcCtD
Atomoxetine—Pruritus—Dexamethasone—ulcerative colitis	0.000151	0.000438	CcSEcCtD
Atomoxetine—Pruritus—Betamethasone—ulcerative colitis	0.000151	0.000438	CcSEcCtD
Atomoxetine—Vomiting—Triamcinolone—ulcerative colitis	0.00015	0.000434	CcSEcCtD
Atomoxetine—Vomiting—Methylprednisolone—ulcerative colitis	0.000149	0.000433	CcSEcCtD
Atomoxetine—Nausea—Hydrocortisone—ulcerative colitis	0.000148	0.000431	CcSEcCtD
Atomoxetine—Rash—Triamcinolone—ulcerative colitis	0.000148	0.000431	CcSEcCtD
Atomoxetine—Dermatitis—Triamcinolone—ulcerative colitis	0.000148	0.00043	CcSEcCtD
Atomoxetine—Rash—Methylprednisolone—ulcerative colitis	0.000148	0.00043	CcSEcCtD
Atomoxetine—Dermatitis—Methylprednisolone—ulcerative colitis	0.000148	0.000429	CcSEcCtD
Atomoxetine—Urticaria—Prednisone—ulcerative colitis	0.000148	0.000429	CcSEcCtD
Atomoxetine—Headache—Triamcinolone—ulcerative colitis	0.000147	0.000428	CcSEcCtD
Atomoxetine—Headache—Methylprednisolone—ulcerative colitis	0.000147	0.000427	CcSEcCtD
Atomoxetine—Abdominal pain—Prednisone—ulcerative colitis	0.000147	0.000427	CcSEcCtD
Atomoxetine—Body temperature increased—Prednisone—ulcerative colitis	0.000147	0.000427	CcSEcCtD
Atomoxetine—Diarrhoea—Betamethasone—ulcerative colitis	0.000146	0.000424	CcSEcCtD
Atomoxetine—Diarrhoea—Dexamethasone—ulcerative colitis	0.000146	0.000424	CcSEcCtD
Atomoxetine—Dizziness—Betamethasone—ulcerative colitis	0.000141	0.00041	CcSEcCtD
Atomoxetine—Dizziness—Dexamethasone—ulcerative colitis	0.000141	0.00041	CcSEcCtD
Atomoxetine—CYP3A4—digestive system—ulcerative colitis	0.000141	0.0199	CbGeAlD
Atomoxetine—Nausea—Triamcinolone—ulcerative colitis	0.00014	0.000406	CcSEcCtD
Atomoxetine—Nausea—Methylprednisolone—ulcerative colitis	0.000139	0.000405	CcSEcCtD
Atomoxetine—CYP2D6—digestive system—ulcerative colitis	0.000139	0.0196	CbGeAlD
Atomoxetine—Vomiting—Betamethasone—ulcerative colitis	0.000136	0.000394	CcSEcCtD
Atomoxetine—Vomiting—Dexamethasone—ulcerative colitis	0.000136	0.000394	CcSEcCtD
Atomoxetine—Rash—Dexamethasone—ulcerative colitis	0.000135	0.000391	CcSEcCtD
Atomoxetine—Rash—Betamethasone—ulcerative colitis	0.000135	0.000391	CcSEcCtD
Atomoxetine—Dermatitis—Betamethasone—ulcerative colitis	0.000134	0.00039	CcSEcCtD
Atomoxetine—Dermatitis—Dexamethasone—ulcerative colitis	0.000134	0.00039	CcSEcCtD
Atomoxetine—Headache—Dexamethasone—ulcerative colitis	0.000134	0.000388	CcSEcCtD
Atomoxetine—Headache—Betamethasone—ulcerative colitis	0.000134	0.000388	CcSEcCtD
Atomoxetine—Asthenia—Prednisone—ulcerative colitis	0.000133	0.000387	CcSEcCtD
Atomoxetine—Pruritus—Prednisone—ulcerative colitis	0.000131	0.000382	CcSEcCtD
Atomoxetine—Diarrhoea—Prednisone—ulcerative colitis	0.000127	0.000369	CcSEcCtD
Atomoxetine—Nausea—Betamethasone—ulcerative colitis	0.000127	0.000368	CcSEcCtD
Atomoxetine—Nausea—Dexamethasone—ulcerative colitis	0.000127	0.000368	CcSEcCtD
Atomoxetine—Propranolol—ABCB1—ulcerative colitis	0.000127	0.00957	CrCbGaD
Atomoxetine—Dizziness—Prednisone—ulcerative colitis	0.000123	0.000357	CcSEcCtD
Atomoxetine—Nortriptyline—ALB—ulcerative colitis	0.000122	0.00922	CrCbGaD
Atomoxetine—Vomiting—Prednisone—ulcerative colitis	0.000118	0.000343	CcSEcCtD
Atomoxetine—Rash—Prednisone—ulcerative colitis	0.000117	0.00034	CcSEcCtD
Atomoxetine—Dermatitis—Prednisone—ulcerative colitis	0.000117	0.00034	CcSEcCtD
Atomoxetine—Headache—Prednisone—ulcerative colitis	0.000116	0.000338	CcSEcCtD
Atomoxetine—HTR2A—liver—ulcerative colitis	0.000113	0.016	CbGeAlD
Atomoxetine—Nausea—Prednisone—ulcerative colitis	0.00011	0.000321	CcSEcCtD
Atomoxetine—CYP3A4—liver—ulcerative colitis	0.000105	0.0149	CbGeAlD
Atomoxetine—Methadone—ABCB1—ulcerative colitis	0.000104	0.00785	CrCbGaD
Atomoxetine—CYP2D6—liver—ulcerative colitis	0.000103	0.0146	CbGeAlD
Atomoxetine—Desipramine—ABCB1—ulcerative colitis	9.59e-05	0.00725	CrCbGaD
Atomoxetine—HTR1D—Signaling Pathways—CXCR1—ulcerative colitis	7.03e-05	0.000579	CbGpPWpGaD
Atomoxetine—HTR2A—GPCR downstream signaling—GNA12—ulcerative colitis	6.97e-05	0.000574	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling by GPCR—GHRL—ulcerative colitis	6.91e-05	0.000569	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling by GPCR—CXCR2—ulcerative colitis	6.91e-05	0.000569	CbGpPWpGaD
Atomoxetine—HTR6—Signaling by GPCR—CALM3—ulcerative colitis	6.89e-05	0.000567	CbGpPWpGaD
Atomoxetine—SLC6A2—Transmembrane transport of small molecules—ADCY5—ulcerative colitis	6.89e-05	0.000567	CbGpPWpGaD
Atomoxetine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—JAK2—ulcerative colitis	6.89e-05	0.000567	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—CXCR1—ulcerative colitis	6.89e-05	0.000567	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling by GPCR—CALM3—ulcerative colitis	6.84e-05	0.000563	CbGpPWpGaD
Atomoxetine—SLC6A4—Circadian rythm related genes—TP53—ulcerative colitis	6.76e-05	0.000557	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling by GPCR—CCL20—ulcerative colitis	6.74e-05	0.000554	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling by GPCR—CALM3—ulcerative colitis	6.7e-05	0.000551	CbGpPWpGaD
Atomoxetine—HTR2A—GPCR downstream signaling—CXCR2—ulcerative colitis	6.61e-05	0.000544	CbGpPWpGaD
Atomoxetine—SLC6A3—Transmembrane transport of small molecules—ABCB1—ulcerative colitis	6.54e-05	0.000538	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling by GPCR—CCR6—ulcerative colitis	6.5e-05	0.000535	CbGpPWpGaD
Atomoxetine—HTR6—GPCR downstream signaling—ADRB2—ulcerative colitis	6.49e-05	0.000534	CbGpPWpGaD
Atomoxetine—HTR1D—GPCR downstream signaling—ADRB2—ulcerative colitis	6.44e-05	0.00053	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—SEL1L—ulcerative colitis	6.34e-05	0.000522	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling by GPCR—GNA12—ulcerative colitis	6.33e-05	0.000521	CbGpPWpGaD
Atomoxetine—HTR2C—GPCR downstream signaling—PTGER4—ulcerative colitis	6.3e-05	0.000519	CbGpPWpGaD
Atomoxetine—HTR1B—GPCR downstream signaling—ADRB2—ulcerative colitis	6.3e-05	0.000519	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—CCL20—ulcerative colitis	6.22e-05	0.000512	CbGpPWpGaD
Atomoxetine—HTR2A—GPCR downstream signaling—CCR6—ulcerative colitis	6.22e-05	0.000512	CbGpPWpGaD
Atomoxetine—SLC6A4—Circadian rythm related genes—IL6—ulcerative colitis	6.19e-05	0.00051	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—CCL20—ulcerative colitis	6.17e-05	0.000508	CbGpPWpGaD
Atomoxetine—SLC6A3—Transmembrane transport of small molecules—ADCY5—ulcerative colitis	6.1e-05	0.000502	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—CCL20—ulcerative colitis	6.05e-05	0.000498	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling by GPCR—CXCR2—ulcerative colitis	6e-05	0.000494	CbGpPWpGaD
Atomoxetine—HTR6—Signaling by GPCR—ADRB2—ulcerative colitis	5.89e-05	0.000485	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—GNA12—ulcerative colitis	5.85e-05	0.000482	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling by GPCR—ADRB2—ulcerative colitis	5.84e-05	0.000481	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—GNA12—ulcerative colitis	5.81e-05	0.000478	CbGpPWpGaD
Atomoxetine—HTR2C—GPCR downstream signaling—GHRL—ulcerative colitis	5.77e-05	0.000475	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling by GPCR—ADRB2—ulcerative colitis	5.72e-05	0.000471	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling by GPCR—PTGER4—ulcerative colitis	5.72e-05	0.000471	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—GNA12—ulcerative colitis	5.68e-05	0.000468	CbGpPWpGaD
Atomoxetine—HTR2A—SIDS Susceptibility Pathways—TNF—ulcerative colitis	5.66e-05	0.000465	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling by GPCR—CCR6—ulcerative colitis	5.64e-05	0.000465	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—CXCR2—ulcerative colitis	5.55e-05	0.000456	CbGpPWpGaD
Atomoxetine—HTR6—GPCR ligand binding—CXCL8—ulcerative colitis	5.54e-05	0.000456	CbGpPWpGaD
Atomoxetine—HTR6—GPCR downstream signaling—ADCY5—ulcerative colitis	5.5e-05	0.000453	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—SEL1L—ulcerative colitis	5.5e-05	0.000453	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—CXCR2—ulcerative colitis	5.5e-05	0.000453	CbGpPWpGaD
Atomoxetine—HTR1D—GPCR ligand binding—CXCL8—ulcerative colitis	5.5e-05	0.000453	CbGpPWpGaD
Atomoxetine—HTR2A—GPCR downstream signaling—PTGER4—ulcerative colitis	5.47e-05	0.00045	CbGpPWpGaD
Atomoxetine—HTR1D—GPCR downstream signaling—ADCY5—ulcerative colitis	5.46e-05	0.00045	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—CXCR2—ulcerative colitis	5.39e-05	0.000444	CbGpPWpGaD
Atomoxetine—HTR1B—GPCR ligand binding—CXCL8—ulcerative colitis	5.39e-05	0.000443	CbGpPWpGaD
Atomoxetine—HTR2C—Class A/1 (Rhodopsin-like receptors)—CXCL8—ulcerative colitis	5.36e-05	0.000441	CbGpPWpGaD
Atomoxetine—HTR1B—GPCR downstream signaling—ADCY5—ulcerative colitis	5.35e-05	0.00044	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism—CHP1—ulcerative colitis	5.34e-05	0.00044	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling by GPCR—GHRL—ulcerative colitis	5.24e-05	0.000431	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—CXCR1—ulcerative colitis	5.22e-05	0.00043	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—CCR6—ulcerative colitis	5.21e-05	0.000429	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—CCR6—ulcerative colitis	5.17e-05	0.000426	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling by GPCR—CALM3—ulcerative colitis	5.07e-05	0.000418	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—CCR6—ulcerative colitis	5.07e-05	0.000417	CbGpPWpGaD
Atomoxetine—HTR2A—GPCR downstream signaling—GHRL—ulcerative colitis	5.01e-05	0.000412	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS1—ulcerative colitis	5e-05	0.000412	CbGpPWpGaD
Atomoxetine—HTR6—Signaling by GPCR—ADCY5—ulcerative colitis	5e-05	0.000411	CbGpPWpGaD
Atomoxetine—NPY1R—Signaling Pathways—JAK2—ulcerative colitis	4.99e-05	0.000411	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling by GPCR—PTGER4—ulcerative colitis	4.97e-05	0.000409	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling by GPCR—ADCY5—ulcerative colitis	4.96e-05	0.000408	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—MAML2—ulcerative colitis	4.94e-05	0.000407	CbGpPWpGaD
Atomoxetine—CYP2D6—Metabolism—CHP1—ulcerative colitis	4.91e-05	0.000404	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—MAML2—ulcerative colitis	4.91e-05	0.000404	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling by GPCR—ADCY5—ulcerative colitis	4.86e-05	0.0004	CbGpPWpGaD
Atomoxetine—NPY1R—Signaling Pathways—RELA—ulcerative colitis	4.83e-05	0.000398	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—MAML2—ulcerative colitis	4.8e-05	0.000395	CbGpPWpGaD
Atomoxetine—HTR2C—GPCR downstream signaling—ADRB2—ulcerative colitis	4.78e-05	0.000393	CbGpPWpGaD
Atomoxetine—HTR2A—Class A/1 (Rhodopsin-like receptors)—CXCL8—ulcerative colitis	4.65e-05	0.000383	CbGpPWpGaD
Atomoxetine—SLC6A2—Transmembrane transport of small molecules—ALB—ulcerative colitis	4.62e-05	0.00038	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism—DLD—ulcerative colitis	4.61e-05	0.000379	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—PTGER4—ulcerative colitis	4.59e-05	0.000378	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—CCL20—ulcerative colitis	4.58e-05	0.000377	CbGpPWpGaD
Atomoxetine—HTR2A—SIDS Susceptibility Pathways—IL6—ulcerative colitis	4.56e-05	0.000376	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—PTGER4—ulcerative colitis	4.56e-05	0.000375	CbGpPWpGaD
Atomoxetine—NPY1R—Signaling Pathways—CXCL8—ulcerative colitis	4.56e-05	0.000375	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling by GPCR—GHRL—ulcerative colitis	4.55e-05	0.000374	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—CXCR1—ulcerative colitis	4.53e-05	0.000373	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—PTGER4—ulcerative colitis	4.46e-05	0.000367	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling by GPCR—CALM3—ulcerative colitis	4.41e-05	0.000363	CbGpPWpGaD
Atomoxetine—NPY1R—Signaling Pathways—IL2—ulcerative colitis	4.35e-05	0.000358	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling by GPCR—ADRB2—ulcerative colitis	4.34e-05	0.000357	CbGpPWpGaD
Atomoxetine—NPY1R—Signaling by GPCR—IL6—ulcerative colitis	4.33e-05	0.000357	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—GNA12—ulcerative colitis	4.31e-05	0.000355	CbGpPWpGaD
Atomoxetine—CYP2D6—Metabolism—DLD—ulcerative colitis	4.24e-05	0.000349	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—GHRL—ulcerative colitis	4.2e-05	0.000346	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—GHRL—ulcerative colitis	4.17e-05	0.000343	CbGpPWpGaD
Atomoxetine—HTR2A—GPCR downstream signaling—ADRB2—ulcerative colitis	4.15e-05	0.000341	CbGpPWpGaD
Atomoxetine—NPY1R—Signaling Pathways—MMP9—ulcerative colitis	4.12e-05	0.000339	CbGpPWpGaD
Atomoxetine—SLC6A3—Transmembrane transport of small molecules—ALB—ulcerative colitis	4.09e-05	0.000337	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—GHRL—ulcerative colitis	4.08e-05	0.000336	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—CXCR2—ulcerative colitis	4.08e-05	0.000336	CbGpPWpGaD
Atomoxetine—HTR2C—GPCR ligand binding—CXCL8—ulcerative colitis	4.08e-05	0.000336	CbGpPWpGaD
Atomoxetine—NPY1R—Signaling Pathways—NFKB1—ulcerative colitis	4.08e-05	0.000336	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—CALM3—ulcerative colitis	4.07e-05	0.000335	CbGpPWpGaD
Atomoxetine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—ulcerative colitis	4.07e-05	0.000335	CbGpPWpGaD
Atomoxetine—HTR2C—GPCR downstream signaling—ADCY5—ulcerative colitis	4.05e-05	0.000334	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—CALM3—ulcerative colitis	4.04e-05	0.000332	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—RIPK2—ulcerative colitis	4.01e-05	0.00033	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—RIPK2—ulcerative colitis	3.98e-05	0.000328	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—CCL20—ulcerative colitis	3.98e-05	0.000328	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—CALM3—ulcerative colitis	3.96e-05	0.000326	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—RIPK2—ulcerative colitis	3.9e-05	0.000321	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—CCR6—ulcerative colitis	3.84e-05	0.000316	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling by GPCR—ADRB2—ulcerative colitis	3.77e-05	0.00031	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—GNA12—ulcerative colitis	3.74e-05	0.000308	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling by GPCR—ADCY5—ulcerative colitis	3.68e-05	0.000303	CbGpPWpGaD
Atomoxetine—NPY1R—Signaling Pathways—STAT3—ulcerative colitis	3.66e-05	0.000302	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—MAML2—ulcerative colitis	3.64e-05	0.0003	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—CXCR2—ulcerative colitis	3.55e-05	0.000292	CbGpPWpGaD
Atomoxetine—HTR2A—GPCR ligand binding—CXCL8—ulcerative colitis	3.54e-05	0.000292	CbGpPWpGaD
Atomoxetine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—ulcerative colitis	3.53e-05	0.000291	CbGpPWpGaD
Atomoxetine—HTR2A—GPCR downstream signaling—ADCY5—ulcerative colitis	3.52e-05	0.00029	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—ADRB2—ulcerative colitis	3.48e-05	0.000286	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—ADRB2—ulcerative colitis	3.45e-05	0.000284	CbGpPWpGaD
Atomoxetine—HTR6—GPCR downstream signaling—JAK2—ulcerative colitis	3.43e-05	0.000282	CbGpPWpGaD
Atomoxetine—HTR1D—GPCR downstream signaling—JAK2—ulcerative colitis	3.41e-05	0.00028	CbGpPWpGaD
Atomoxetine—NPY1R—Signaling Pathways—TGFB1—ulcerative colitis	3.4e-05	0.000279	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—PTGER4—ulcerative colitis	3.38e-05	0.000278	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—ADRB2—ulcerative colitis	3.38e-05	0.000278	CbGpPWpGaD
Atomoxetine—HTR1B—GPCR downstream signaling—JAK2—ulcerative colitis	3.33e-05	0.000274	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—CCR6—ulcerative colitis	3.33e-05	0.000274	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—CHP1—ulcerative colitis	3.21e-05	0.000264	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling by GPCR—ADCY5—ulcerative colitis	3.2e-05	0.000263	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—MAML2—ulcerative colitis	3.16e-05	0.00026	CbGpPWpGaD
Atomoxetine—HTR6—GPCR downstream signaling—CXCL8—ulcerative colitis	3.13e-05	0.000258	CbGpPWpGaD
Atomoxetine—HTR6—Signaling by GPCR—JAK2—ulcerative colitis	3.12e-05	0.000257	CbGpPWpGaD
Atomoxetine—HTR1D—GPCR downstream signaling—CXCL8—ulcerative colitis	3.11e-05	0.000256	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—GHRL—ulcerative colitis	3.1e-05	0.000255	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling by GPCR—JAK2—ulcerative colitis	3.09e-05	0.000255	CbGpPWpGaD
Atomoxetine—HTR1B—GPCR downstream signaling—CXCL8—ulcerative colitis	3.04e-05	0.000251	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling by GPCR—JAK2—ulcerative colitis	3.03e-05	0.000249	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—CALM3—ulcerative colitis	3e-05	0.000247	CbGpPWpGaD
Atomoxetine—HTR6—GPCR downstream signaling—IL2—ulcerative colitis	2.99e-05	0.000246	CbGpPWpGaD
Atomoxetine—HTR1D—GPCR downstream signaling—IL2—ulcerative colitis	2.97e-05	0.000245	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—ADCY5—ulcerative colitis	2.95e-05	0.000243	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—RIPK2—ulcerative colitis	2.95e-05	0.000243	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—PTGER4—ulcerative colitis	2.94e-05	0.000242	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—ADCY5—ulcerative colitis	2.93e-05	0.000241	CbGpPWpGaD
Atomoxetine—HTR1B—GPCR downstream signaling—IL2—ulcerative colitis	2.91e-05	0.000239	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—ADCY5—ulcerative colitis	2.87e-05	0.000236	CbGpPWpGaD
Atomoxetine—HTR6—Signaling by GPCR—CXCL8—ulcerative colitis	2.84e-05	0.000234	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling by GPCR—CXCL8—ulcerative colitis	2.82e-05	0.000232	CbGpPWpGaD
Atomoxetine—NPY1R—Signaling Pathways—TP53—ulcerative colitis	2.8e-05	0.00023	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—DLD—ulcerative colitis	2.77e-05	0.000228	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling by GPCR—CXCL8—ulcerative colitis	2.76e-05	0.000227	CbGpPWpGaD
Atomoxetine—HTR6—Signaling by GPCR—IL2—ulcerative colitis	2.72e-05	0.000224	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling by GPCR—IL2—ulcerative colitis	2.7e-05	0.000222	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—GHRL—ulcerative colitis	2.69e-05	0.000221	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling by GPCR—IL2—ulcerative colitis	2.64e-05	0.000217	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—CALM3—ulcerative colitis	2.6e-05	0.000214	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—RIPK2—ulcerative colitis	2.56e-05	0.000211	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—ADRB2—ulcerative colitis	2.56e-05	0.000211	CbGpPWpGaD
Atomoxetine—NPY1R—Signaling Pathways—IL6—ulcerative colitis	2.56e-05	0.000211	CbGpPWpGaD
Atomoxetine—HTR2C—GPCR downstream signaling—JAK2—ulcerative colitis	2.53e-05	0.000208	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	2.44e-05	0.000201	CbGpPWpGaD
Atomoxetine—HTR2C—GPCR downstream signaling—CXCL8—ulcerative colitis	2.31e-05	0.00019	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling by GPCR—JAK2—ulcerative colitis	2.3e-05	0.000189	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism—PTGS1—ulcerative colitis	2.23e-05	0.000183	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—ADRB2—ulcerative colitis	2.22e-05	0.000183	CbGpPWpGaD
Atomoxetine—HTR2C—GPCR downstream signaling—IL2—ulcerative colitis	2.2e-05	0.000181	CbGpPWpGaD
Atomoxetine—HTR2A—GPCR downstream signaling—JAK2—ulcerative colitis	2.19e-05	0.000181	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	2.19e-05	0.00018	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—ADCY5—ulcerative colitis	2.17e-05	0.000179	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling by GPCR—CXCL8—ulcerative colitis	2.09e-05	0.000172	CbGpPWpGaD
Atomoxetine—CYP2D6—Metabolism—PTGS1—ulcerative colitis	2.05e-05	0.000169	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism—CALM3—ulcerative colitis	2.01e-05	0.000165	CbGpPWpGaD
Atomoxetine—HTR2A—GPCR downstream signaling—CXCL8—ulcerative colitis	2e-05	0.000165	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling by GPCR—IL2—ulcerative colitis	2e-05	0.000165	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling by GPCR—JAK2—ulcerative colitis	1.99e-05	0.000164	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	1.92e-05	0.000158	CbGpPWpGaD
Atomoxetine—HTR2A—GPCR downstream signaling—IL2—ulcerative colitis	1.91e-05	0.000158	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—ADCY5—ulcerative colitis	1.89e-05	0.000155	CbGpPWpGaD
Atomoxetine—CYP2D6—Metabolism—CALM3—ulcerative colitis	1.85e-05	0.000152	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—JAK2—ulcerative colitis	1.84e-05	0.000152	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—JAK2—ulcerative colitis	1.83e-05	0.00015	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling by GPCR—CXCL8—ulcerative colitis	1.82e-05	0.00015	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—JAK2—ulcerative colitis	1.79e-05	0.000147	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—RELA—ulcerative colitis	1.78e-05	0.000147	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—RELA—ulcerative colitis	1.77e-05	0.000146	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling by GPCR—IL2—ulcerative colitis	1.74e-05	0.000143	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—RELA—ulcerative colitis	1.73e-05	0.000143	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—CXCL8—ulcerative colitis	1.68e-05	0.000138	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—CXCL8—ulcerative colitis	1.67e-05	0.000137	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—CXCL8—ulcerative colitis	1.63e-05	0.000134	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—IL2—ulcerative colitis	1.61e-05	0.000132	CbGpPWpGaD
Atomoxetine—HTR6—Signaling by GPCR—IL6—ulcerative colitis	1.6e-05	0.000132	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—IL2—ulcerative colitis	1.59e-05	0.000131	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling by GPCR—IL6—ulcerative colitis	1.59e-05	0.000131	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism—ABCB1—ulcerative colitis	1.56e-05	0.000128	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—IL2—ulcerative colitis	1.56e-05	0.000128	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling by GPCR—IL6—ulcerative colitis	1.55e-05	0.000128	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—MMP9—ulcerative colitis	1.52e-05	0.000125	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—MMP9—ulcerative colitis	1.51e-05	0.000124	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—NFKB1—ulcerative colitis	1.5e-05	0.000124	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—NFKB1—ulcerative colitis	1.49e-05	0.000123	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—MMP9—ulcerative colitis	1.48e-05	0.000122	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—NFKB1—ulcerative colitis	1.46e-05	0.00012	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism—ADCY5—ulcerative colitis	1.46e-05	0.00012	CbGpPWpGaD
Atomoxetine—CYP2D6—Metabolism—ABCB1—ulcerative colitis	1.44e-05	0.000118	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—JAK2—ulcerative colitis	1.36e-05	0.000112	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—STAT3—ulcerative colitis	1.35e-05	0.000111	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—STAT3—ulcerative colitis	1.34e-05	0.00011	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—PTGS1—ulcerative colitis	1.34e-05	0.00011	CbGpPWpGaD
Atomoxetine—CYP2D6—Metabolism—ADCY5—ulcerative colitis	1.34e-05	0.00011	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—STAT3—ulcerative colitis	1.31e-05	0.000108	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—RELA—ulcerative colitis	1.31e-05	0.000108	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—TGFB1—ulcerative colitis	1.25e-05	0.000103	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—TGFB1—ulcerative colitis	1.24e-05	0.000102	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—CXCL8—ulcerative colitis	1.24e-05	0.000102	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—TGFB1—ulcerative colitis	1.22e-05	0.0001	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—CALM3—ulcerative colitis	1.21e-05	9.93e-05	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—IL2—ulcerative colitis	1.18e-05	9.73e-05	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—JAK2—ulcerative colitis	1.18e-05	9.69e-05	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling by GPCR—IL6—ulcerative colitis	1.18e-05	9.68e-05	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—RELA—ulcerative colitis	1.14e-05	9.38e-05	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—MMP9—ulcerative colitis	1.12e-05	9.21e-05	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—NFKB1—ulcerative colitis	1.11e-05	9.11e-05	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism—PPARG—ulcerative colitis	1.09e-05	8.94e-05	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—CXCL8—ulcerative colitis	1.07e-05	8.84e-05	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—TP53—ulcerative colitis	1.03e-05	8.49e-05	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—IL2—ulcerative colitis	1.03e-05	8.45e-05	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—TP53—ulcerative colitis	1.02e-05	8.42e-05	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling by GPCR—IL6—ulcerative colitis	1.02e-05	8.41e-05	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—TP53—ulcerative colitis	1e-05	8.25e-05	CbGpPWpGaD
Atomoxetine—CYP2D6—Metabolism—PPARG—ulcerative colitis	9.99e-06	8.22e-05	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—STAT3—ulcerative colitis	9.95e-06	8.19e-05	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism—ALB—ulcerative colitis	9.76e-06	8.03e-05	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—MMP9—ulcerative colitis	9.72e-06	8e-05	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—NFKB1—ulcerative colitis	9.62e-06	7.91e-05	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—IL6—ulcerative colitis	9.44e-06	7.77e-05	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—ABCB1—ulcerative colitis	9.38e-06	7.72e-05	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—IL6—ulcerative colitis	9.37e-06	7.71e-05	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—TGFB1—ulcerative colitis	9.22e-06	7.59e-05	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—IL6—ulcerative colitis	9.17e-06	7.55e-05	CbGpPWpGaD
Atomoxetine—CYP2D6—Metabolism—ALB—ulcerative colitis	8.98e-06	7.39e-05	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—ADCY5—ulcerative colitis	8.75e-06	7.2e-05	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—STAT3—ulcerative colitis	8.64e-06	7.11e-05	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism—PTGS2—ulcerative colitis	8.54e-06	7.03e-05	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—TGFB1—ulcerative colitis	8.01e-06	6.59e-05	CbGpPWpGaD
Atomoxetine—CYP2D6—Metabolism—PTGS2—ulcerative colitis	7.85e-06	6.47e-05	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—TP53—ulcerative colitis	7.59e-06	6.25e-05	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—IL6—ulcerative colitis	6.95e-06	5.72e-05	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—TP53—ulcerative colitis	6.59e-06	5.43e-05	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—PPARG—ulcerative colitis	6.53e-06	5.37e-05	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—IL6—ulcerative colitis	6.04e-06	4.97e-05	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—ALB—ulcerative colitis	5.87e-06	4.83e-05	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—PTGS2—ulcerative colitis	5.14e-06	4.23e-05	CbGpPWpGaD
